Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rosing

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2002
The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma modelM van der Neut Kolfschoten, R J Dirven, G Tans, et al.
Blood Cells|January 1, 1983
Platelet membrane involvement in blood coagulationH C Hemker, J L van Rijn, J Rosing, et al.
The Journal of Biological Chemistry|August 12, 1994
Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chainH M Bakker, G Tans, M C Thomassen, et al.
Thrombosis and Haemostasis|October 8, 2011
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsiaS N Tchaikovski, M C L G D Thomassen, S-D Costa, et al.
Thrombosis and Haemostasis|September 1, 1996
A prothrombinase-based assay for detection of resistance to activated protein CG A Nicolaes, M C Thomassen, R van Oerle, et al.
Blood|June 1, 1985
Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorderJ Rosing, E M Bevers, P Comfurius, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutationJ M Brugge, P Simioni, F Bernardi, et al.
The Journal of Biological Chemistry|June 10, 1994
Activation of human factor V by meizothrombinG Tans, G A Nicolaes, M C Thomassen, et al.
The New England Journal of Medicine|May 18, 2001
Oral contraceptives and the risk of venous thrombosisJ P Vandenbroucke, J Rosing, K W Bloemenkamp, et al.
European Journal of Biochemistry|August 15, 1992
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CH M Bakker, G Tans, T Janssen-Claessen, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2002
The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma modelM van der Neut Kolfschoten, R J Dirven, G Tans, et al.
Blood Cells|January 1, 1983
Platelet membrane involvement in blood coagulationH C Hemker, J L van Rijn, J Rosing, et al.
The Journal of Biological Chemistry|August 12, 1994
Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chainH M Bakker, G Tans, M C Thomassen, et al.
Thrombosis and Haemostasis|October 8, 2011
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsiaS N Tchaikovski, M C L G D Thomassen, S-D Costa, et al.
Thrombosis and Haemostasis|September 1, 1996
A prothrombinase-based assay for detection of resistance to activated protein CG A Nicolaes, M C Thomassen, R van Oerle, et al.
Blood|June 1, 1985
Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorderJ Rosing, E M Bevers, P Comfurius, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutationJ M Brugge, P Simioni, F Bernardi, et al.
The Journal of Biological Chemistry|June 10, 1994
Activation of human factor V by meizothrombinG Tans, G A Nicolaes, M C Thomassen, et al.
The New England Journal of Medicine|May 18, 2001
Oral contraceptives and the risk of venous thrombosisJ P Vandenbroucke, J Rosing, K W Bloemenkamp, et al.
European Journal of Biochemistry|August 15, 1992
The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CH M Bakker, G Tans, T Janssen-Claessen, et al.
Pageof 15